Avricore Health Stock Today

AVCR Stock  CAD 0.17  0.01  5.56%   


7 of 100


Odds Of Distress

Less than 47

About Average
Avricore Health is selling for under 0.17 as of the 23rd of June 2024; that is -5.56 percent down since the beginning of the trading day. The stock's lowest day price was 0.17. Avricore Health has 47 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for Avricore Health are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of May 2024 and ending today, the 23rd of June 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Health Care
Avricore Health Inc. manufactures and sells over-the-counter products in Canada. Avricore Health Inc. was founded in 1996 and is headquartered in Vancouver, Canada. AVRICORE HEALTH operates under Drug Manufacturers - Specialty Generic classification in Canada and is traded on TSX Venture Exchange.. The company has 99.64 M outstanding shares of which 85 shares are presently shorted by private and institutional investors with about 0.0 days to cover all short positions. More on Avricore Health

Moving together with Avricore Stock

  0.69WMT Walmart Inc CDRPairCorr
  0.71AAPL Apple Inc CDRPairCorr

Moving against Avricore Stock


Avricore Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Avricore Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Avricore Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Thematic IdeaHealth Management (View all Themes)
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Management, Health Care, Biotechnology, Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors)
Avricore Health's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Avricore Health's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Avricore Health can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Avricore Health's financial leverage. It provides some insight into what part of Avricore Health's total assets is financed by creditors.
Avricore Health cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Avricore Health has accumulated 40 K in total debt. Avricore Health has a current ratio of 1.76, which is within standard range for the sector. Debt can assist Avricore Health until it has trouble settling it off, either with new capital or with free cash flow. So, Avricore Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Avricore Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Avricore to invest in growth at high rates of return. When we think about Avricore Health's use of debt, we should always consider it together with cash and equity.

End Period Cash Flow

Avricore Health (AVCR) is traded on TSX Venture Exchange in Canada and employs 5 people. Avricore Health is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.44 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Avricore Health's market, we take the total number of its shares issued and multiply it by Avricore Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Avricore Health operates under Biotechnology sector and is part of Health Care industry. The entity has 99.64 M outstanding shares of which 85 shares are presently shorted by private and institutional investors with about 0.0 days to cover all short positions. Avricore Health has accumulated about 122.09 K in cash with 660.4 K of positive cash flow from operations.
Check Avricore Health Probability Of Bankruptcy
Ownership Allocation
Avricore Health retains a total of 99.64 Million outstanding shares. Avricore Health shows 9.7 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Avricore Ownership Details

Avricore Health Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Avricore Health market risk premium is the additional return an investor will receive from holding Avricore Health long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Avricore Health. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Avricore Health's alpha and beta are two of the key measurements used to evaluate Avricore Health's performance over the market, the standard measures of volatility play an important role as well.

Avricore Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Avricore Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Suggestion Now


Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module

Avricore Health Corporate Management

Elected by the shareholders, the Avricore Health's board of directors comprises two types of representatives: Avricore Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avricore. The board's role is to monitor Avricore Health's management team and ensure that shareholders' interests are well served. Avricore Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avricore Health's outside directors are responsible for providing unbiased perspectives on the board's policies.

Additional Tools for Avricore Stock Analysis

When running Avricore Health's price analysis, check to measure Avricore Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avricore Health is operating at the current time. Most of Avricore Health's value examination focuses on studying past and present price action to predict the probability of Avricore Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avricore Health's price. Additionally, you may evaluate how the addition of Avricore Health to your portfolios can decrease your overall portfolio volatility.